translational oncologist at Duke Cancer Institute / director CLL & Lymphoma research program / views and tweets are my own
Joined December 2019
- Tweets 67
- Following 261
- Followers 483
- Likes 458
4 Photos and videos
Danielle M. Brander retweeted
27 Jan 2024
CME Opportunity: Join #DukeDebates2024, presented by #DukeCancerNetwork in collaboration with @DukeCancer.
April 12-14, 2024, Hilton Head, SC
Register here: bit.ly/DukeDebates
CME credit available. Earn up to 12 MOC Part 2 points.
#DukeCancerInstitute #MedEd
3
3
1,137
Danielle M. Brander retweeted
26 Apr 2022
Ask your doctor if you are considered high risk by the CLLIPI score. If so, you may qualify for this exciting study. #CLL @SWOG @BrianHill_MDPhD @mshadman @anthonymatomd @dbranderMD @DanilovLab
26 Apr 2022
Venetoclax obinutuzumab combo is approved as front-line tx for pts w #CLL. Can intervening early w this combo vs waiting for symptoms lengthen survival for pts w high-risk (CLL-IPI of 4 ) CLL or small #lymphocytic #lymphoma? @SWOG S1925 trial. SWOG.org/clinical-trials/S19… @NRGonc
3
13
Danielle M. Brander retweeted
28 Jul 2021
Outstanding commentary by @DebbieMStephens from @huntsmancancer on the recent publication on the ELEVATE-RR study comparing ibrutinib and acalabrutinib in R/R CLL in @JCO_ASCO ascopubs.org/doi/abs/10.1200…
2
6
36
Danielle M. Brander retweeted
24 Jun 2021
Just out - our multicenter effort to dissect comorbidities in CLL @mshadman @DrDanPersky @dbranderMD @matthew_mei @jonathonbcohen @KrishPatelMD @BrianHill_MDPhD @DebbieMStephens clincancerres.aacrjournals.o…
1
6
26
Danielle M. Brander retweeted
1 Jan 2021
Thanks to the @CllSociety for all you do for our patients. Happy New Year!
31 Dec 2020
To keep our CLL patients healthy, we use our Brains! 100s of ground-breaking CLL-focused clinical trials & 1000s of hours of compassionate clinical care inform #CLLSociety’s Med Ad Board. Thank you! @DrMDavids @dbranderMD @DebbieMStephens @ASkarbnik bit.ly/2KpJ7A5
1
9
Danielle M. Brander retweeted
19 Dec 2020
Important MURANO tox ax
@anthonymatomd @jeff_sharman et al
28% premature d/c VR<2y
⬇️ PFS in prem d/c ven for any reason (PD excluded;p<0.0001) due to AE
Interrupt for AE 69% / dose ⬇️ 23% both no impact on PFS/OS
Tox mx continued Rx important for VenR PFS outcome #CLL #lymsm
2
8
Danielle M. Brander retweeted
#ASH20 poster by @LindsayReinMD @DukeHMCT @dukemedicine @DukeCancer
Phase I trial incorporating NK cells for patients w/ #CML & MRD after TKI therapy. #leusm
bit.ly/3osWQ7x
2
3
6 Dec 2020
There may not have been an official ASH run this year, but anyone else still get in their #FauciFour ? If daily running is the secret to Dr Fauci leading the nation through this chaos, may I never stop.
Also, the San Diego skyline has nothing on my view.
#IRunForASH
1
24
4 Dec 2020
Flashback Friday and my upcoming first Twitter-versary.
This tweet from an amazing #cll leader, along with a little help from @chadinabhan and @anthonymatomd finally got me on board. Looking forward to #ash20 highlights and my first ash on Twitter.
2
2
11
4 Dec 2020
To teach is to learn, twice
And thankful for this opportunity from #ASH20, twice -
to learn from so many others but also to work on this with an amazing fellow @DukeFellows, Dr Ashley Hanlon @amilliga, that has taught me so much and co authored this chapter #dukefamily
1
12
Danielle M. Brander retweeted
3 Dec 2020
We are so excited to welcome @_joycehwang @andrewpeseski @FahminB_MDPhD Drs. Kathrine DiNardo, Cameron Oswalt, Grayce Selig, and Cameron Wood to the Duke Heme/Onc Fellowship Program! We are so excited to have you join our wards and clinics in July 2021! @DukeCancer @dukemedicine
1
4
32
4 Dec 2020
Intolerance is a failure of the medication for that given patient, patients don’t fail therapy.
Grateful to be a part of this collaborative effort @DukeHMCT and for all trials aimed at the unmet need of intolerance. @anthonymatomd @AndreaSitlinger and many others
1
16
Danielle M. Brander retweeted
11 Oct 2020
Please see our publication of the largest cohort of patients #Hodgkin transformation in #CLL patients. haematologica.org/article/vi… Planning more research in this patient population. Thanks for a great collaborative effort. @huntsmancancer @UUtah. @UofUHealth
7
11
36
Danielle M. Brander retweeted
11 Oct 2020
Outcome of #Hodgkin arising from #CLL. collaboration led by @DebbieMStephens. haematologica.org/article/vi…
@dbranderMD @DrMDavids @anthonymatomd
@fredhutch @SeattleCCA
1
3
9
Danielle M. Brander retweeted
8 Oct 2020
🎉🎉 Congratulations to @BarbAlexanderMD, who will be the new president of @IDSAInfo. "The critical role of ID physicians & scientists has never been more apparent as it is today."
idsociety.org/news--publicat…
4
8
96
19 Sep 2020
every point exactly, @JasAWebb - easy to feel defeated hearing this news, but will take that energy and use it to inspire action towards the many challenges that face us...
1
14